Ionis Pharmaceuticals Unearned Premium on Insurance Contract (Quarterly) Analysis

Ionis Pharmaceuticals, Inc. (IONS)

81.53 +2.09 (+2.63%) USD | NASDAQ | Jan 22, 12:59

View Unearned Premium on Insurance Contract (Quarterly) for IONS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Unearned Premium on Insurance Contract (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Unearned Premium on Insurance Contract (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Unearned Premium on Insurance Contract (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	--
Pfizer Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Biogen, Inc.	--
Cogent Biosciences, Inc.	--